A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

NCT01497197 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

174

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated as per sponsor's decision

Conditions

Infertility
Fertility
Follicle Stimulating Hormone Deficiency

Interventions

DRUG: GONAL-f®
DRUG: Luveris®
BIOLOGICAL: Recombinant human chorionic gonadotropin (r-hCG)

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]